PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 25, 2020JCI Insight22 citationsOpen Access

Chamber-specific transcriptional responses in atrial fibrillation

CLCatherine E. LipovskyJJJesús JiménezQGQiusha Guo

Key Result

Human left atrial cardiomyocytes exhibited Notch pathway activation and an increased >4n ploidy population (13% vs 7%, p<0.001) in patients with atrial fibrillation and heart failure compared to nonfailing hearts.

Study Design

Type

Observational (n=17)

Multicenter

No

Structured PICO

P
Population
Human cardiomyocyte nuclei from nonfailing donor hearts (n=3-7), explanted hearts with end-stage heart failure (n=3), and end-stage heart failure with a history of atrial fibrillation (n=5), alongside a doxycycline-inducible murine genetic model of Notch activation (iNICD).
I
Intervention
Transient activation of Notch signaling in adult murine cardiomyocytes
C
Comparator
Nonfailing controls and heart failure alone (human); unactivated controls (murine)
O
Outcome
Chamber-specific transcriptomic differences and cellular electrophysiologic responses (action potential duration, upstroke velocity)surrogate

Chamber-specific Notch pathway activation in left atrial cardiomyocytes increases ploidy and alters electrophysiology, creating a vulnerable substrate for atrial fibrillation.

Main Result

Absolute Event Rate: 13% vs 7%

p-value: p=<0.001

Limitations

  • The study only focused on human AF in the setting of HF, and findings may not be relevant to AF in other contexts.
  • Limitations in atrial tissue availability prohibited a thorough analysis of the effect of ploidy on human atrial gene expression in AF.
  • Due to previously acquired patient demographics during initial tissue procurement, there is a potential for underrepresentation of clinically relevant data.

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia, yet the molecular signature of the vulnerable atrial substrate is not well understood. Here, we delineated a distinct transcriptional signature in right versus left atrial cardiomyocytes (CMs) at baseline and identified chamber-specific gene expression changes in patients with a history of AF in the setting of end-stage heart failure (AF+HF) that are not present in heart failure alone (HF). We observed that human left atrial (LA) CMs exhibited Notch pathway activation and increased ploidy in AF+HF but not in HF alone. Transient activation of Notch signaling within adult CMs in a murine genetic model is sufficient to increase ploidy in both atrial chambers. Notch activation within LA CMs generated a transcriptomic fingerprint resembling AF, with dysregulation of transcription factor and ion channel genes, including Pitx2, Tbx5, Kcnh2, Kcnq1, and Kcnip2. Notch activation also produced distinct cellular electrophysiologic responses in LA versus right atrial CMs, prolonging the action potential duration (APD) without altering the upstroke velocity in the left atrium and reducing the maximal upstroke velocity without altering the APD in the right atrium. Our results support a shared human/murine model of increased Notch pathway activity predisposing to AF.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lipovsky et al. (2020) conducted an observational in Atrial fibrillation and heart failure (n=17). Atrial fibrillation with heart failure (AF+HF) vs. Nonfailing hearts (NF) and heart failure alone (HF) was evaluated on >4n cardiomyocyte nuclei population in left atrium (AF+HF vs NF) (p=<0.001). Human left atrial cardiomyocytes exhibited Notch pathway activation and an increased >4n ploidy population (13% vs 7%, p<0.001) in patients with atrial fibrillation and heart failure compared to nonfailing hearts.

synapsesocial.com/papers/6a15604879ff98d0de4e8962https://doi.org/10.1172/jci.insight.135319
Ask AI
Helpful
Bookmark
Share
View Full Paper